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a b s t r a c t
Background: Previous studies have suggested a possible link between exposure to inﬂuenza in utero and
bipolar disorder in adulthood. Using data from a prospective birth cohort, we aimed to test for an as-
sociation between exposure to gestational inﬂuenza and the experience of hypomania assessed in early
adulthood.
Methods: We used data on 2957 participants from the Avon Longitudinal Study of Parents and Children
(ALSPAC). The two main outcomes of interest were hypomania, assessed using the Hypomania Checklist
(HCL-32) at age 22–23, and ‘hypomania plus previous psychotic experiences (PE)’. Maternally-reported
gestational inﬂuenza was the exposure of interest. Multivariable logistic regression was used and esti-
mates of association were adjusted for a range of possible confounding factors, including maternal
smoking in pregnancy.
Results: Relative to controls, rates of exposure to gestational inﬂuenza were higher for participants with
hypomania (24.0%) and for participants with ‘hypomania plus PE’ (34.2%), but univariate and multi-
variable analyses of an association between gestational inﬂuenza and hypomania (with and without
previous PE) were not signiﬁcant.
Limitations: The response rate to those who were sent the HCL-32 questionnaire was 36.8%. As a result,
some analyses may have been under-powered to detect a true effect. Inﬂuenza infection during preg-
nancy was self-reported by mothers.
Conclusions: In this prospective population study, gestational inﬂuenza was not identiﬁed as a clear risk
factor for lifetime hypomania or for ‘hypomania with PEs’ in young adult offspring. It is possible that
previous reports of an association between gestational inﬂuenza and bipolar disorder in adulthood have
been confounded by factors such as maternal smoking during pregnancy.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Bipolar disorder (BD) affects at least 2% of the global population
and is characterised by episodes of depression alternating with
episodes of mania or hypomania (Goodwin and Jamison, 2007). It
is associated with signiﬁcant psychological, social, occupational
and physical health morbidity, as well as premature mortality due
to suicide and cardiometabolic disease (Goodwin and Jamison,
2007; Walker et al., 2015). Our current understanding of the
etiology of BD suggests that it occurs as a consequence of complex
interactions between multiple genetic risk factors of small effect
and non-genetic factors such as childhood trauma, adverse life
events and substance misuse (Garno et al., 2005; Phillips and
Kupfer, 2013). In recent years, autoimmunity and aberrant in-
ﬂammatory processes have also been implicated in the patho-
physiology of BD, alongside other mood and psychotic disorders
such as major depression and schizophrenia (Berk et al., 2013;
Dickerson et al., 2007; Frommberger et al., 1997; Harrison, 2013;
Khandaker et al., 2015; Krishnadas and Cavanagh, 2012). One of
the potential mechanisms of the association between neuroin-
ﬂammation and psychiatric disorders might be infection in utero
acting as a trigger for a cascade of abnormal immune responses
during early development (Berk et al., 2013; Khandaker et al.,
2012; Khandaker et al., 2013).
Recent work suggests that gestational inﬂuenza (infection oc-
curring during pregnancy) may be a risk factor for BD in adult
offspring, however, not all studies have found an association
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(Simanek and Meier, 2015). Parboosing and colleagues conducted
a nested case-control analysis of 92 BD cases and 722 controls
within the Child Health and Development Study (CHDS) in the
United States (Parboosing et al., 2013). They reported an associa-
tion between self-reported gestational inﬂuenza and BD with and
without psychotic symptoms, which appeared to be speciﬁc to
inﬂuenza exposure during the third trimester. However, a sub-
sequent analysis of the same sample, which this time used ser-
ologically-documented gestational inﬂuenza as the exposure of
interest, did not ﬁnd an association with BD in offspring, but did
ﬁnd that gestational inﬂuenza increased the risk of BD with psy-
chotic features (Canetta et al., 2014). Alongside evidence that ge-
stational inﬂuenza may be a risk factor for schizophrenia in off-
spring (Brown and Derkits, 2010), this suggests that prenatal ex-
posure to inﬂuenza may be a non-speciﬁc risk factor for psychosis
or severe psychopathology, rather than speciﬁc for a diagnostic
grouping such as schizophrenia or BD.
Additionally, maternal smoking during pregnancy is known to
be associated with psychotic experiences during adolescence
(Zammit et al., 2009b) and schizophrenia in adulthood (Statho-
poulou et al., 2013). Although the CHDS studies cited above ad-
justed for factors such as maternal age, education and psychiatric
history, neither study adjusted for maternal smoking during
pregnancy.
Our study seeks to complement and extend the literature in
this area by making use of comprehensive prospective data from
the Avon Longitudinal Study of Parents and Children (ALSPAC)
(Boyd et al., 2013). Speciﬁcally, we assess whether gestational in-
ﬂuenza is a risk factor for lifetime hypomania assessed in young
adulthood (with and without a history of psychotic experiences,
PE), while taking account of a wider range of potential con-
founding factors than has been considered in previous studies of
this research question.
2. Methods
2.1. Description of cohort and study sample
The ALSPAC birth cohort is comprised of all live births in the
County of Avon, UK, with expected due dates between April 1991
and December 1992. The initial cohort consisted of 14,062 live
births, with 13,998 alive at one year (http://www.bristol.ac.uk/al
spac/). The study website contains details of all the data that are
available through a fully searchable data dictionary (http://www.
bris.ac.uk/alspac/researchers/data-access/data-dictionary/). Ethical
approval for the study was obtained from the ALSPAC Ethics and
Law Committee and Local Research Ethics Committees.
From birth, parents completed regular questionnaires about all
aspects of their child's health and development. From age 7, chil-
dren attended assessment centres to participate in tests and in-
terviews on an annual basis. To date, ALSPAC data have been used
in a wide range of epidemiological studies in mental health (Fraser
et al., 2013; Niarchou et al., 2015). In this study, we assess data on
the 2957 ALSPAC participants who completed an assessment of
the primary outcome of interest, namely lifetime experience of
hypomania, at age 22–23.
2.2. Sample selection
From the original ALSPAC cohort, 9359 young adults were in-
vited to complete the “Your Life Now (at age 21þ)” assessments,
which included the HCL-32 questionnaire. Participants could
choose from paper or online versions. A total of 3447 participants
returned the questionnaire (36.8% response rate), including 2957
with complete answers (representing our study sample).
2.3. Outcome measures
2.3.1. Primary outcome: lifetime hypomania assessed in young
adulthood
Hypomania was deﬁned using the Hypomania Checklist (HCL-
32), assessed when participants were aged 22–23 years. The HCL-
32 is a self-completed questionnaire for lifetime experience of
manic features (Angst et al., 2005). It asks that people consider a
time when they were in a “high or hyper” state and endorse a
number of statements about their emotions, thoughts and beha-
viours at this time. Examples of the 32 symptom statements are: “I
think faster”; “I make more jokes or puns when I am talking”; and “I
take more risks in my daily life”. The questionnaire also asks about
the duration of such episodes and impact on family, social and
work life (Carvalho et al., 2014; Court et al., 2014). Although in-
itially developed as a screening instrument for use in people di-
agnosed with depressive disorders, it is also a sensitive screening
tool in non-clinical settings, including samples of young (Meyer
et al., 2007; Meyer et al., 2014).
We deﬁned lifetime history of hypomania in line with previous
approaches for studies of this nature, namely: a score of 14 or
more out of 32 hypomanic features; plus at least one response of
either “negative consequences” or “negative plus positive con-
sequences”; plus a report that these mood changes caused a re-
action in others; plus a duration of “2–3 days” or more. Overall, this
deﬁnition of hypomania, which includes severity, impairment and
duration criteria, is more conservative than most other studies,
which have tended to use only the threshold score of 14 (Hardoy
et al., 2005; Meyer et al., 2014). We chose a duration criterion of 2–
3 days or more because the 4 day threshold within DSM excludes
many individuals with bipolar disorder type II (Goldberg et al.,
2009; Pini et al., 2005) and because two days is the modal dura-
tion of hypomania for individuals with bipolar II disorder (Angst
and Cassano, 2005; Benazzi, 2001). Based on previous work in
non-clinical samples, we expected that between 5 and 10% of re-
spondents might satisfy our criteria for hypomania (Holtmann
et al., 2009; Meyer et al., 2007).
2.3.2. Secondary outcome: hypomania with previous psychotic ex-
periences (PE)
Hypomania plus previous PE was also studied as an outcome.
PE were assessed using the semi-structured Psychosis-Like
Symptoms interview (PLIKSi) administered at ages 12 and 18
(Zammit et al., 2009a). The PLIKSi consists of 12 core questions
covering hallucinations (visual and auditory); delusions (delusions
of being spied on, persecution, thoughts being read, reference,
control, grandiose ability and other unspeciﬁed delusions); and
experiences of thought interference (thought broadcasting, inser-
tion and withdrawal) over the past 6 months. Clinical cross-
questioning and probing was used to establish the presence of
symptoms, and coding of all items followed the glossary deﬁni-
tions and rating rules for SCAN (Schedule for Clinical Assessment
in Neuropsychiatry). PE were coded as present if one or more of
the experiences was rated as ‘suspected or deﬁnitely present’ by a
trained psychologist. Unclear responses after probing were always
‘rated down’, and symptoms only rated as deﬁnite when a credible
example was provided. In our analysis we included only symptoms
that could not be directly attributed to falling asleep/waking or to
fever and were reported either in the PLIKSi at age 12 or in the
PLIKSi at age 18 (Horwood et al., 2008; Zammit et al., 2013).
2.3.3. Exposure of interest: gestational inﬂuenza
Exposure to inﬂuenza in utero was based on maternal re-
sponses to speciﬁc questions about infection which were assessed
at three time points: 18 weeks gestation, 32 weeks gestation, and
8 weeks post-partum. Respectively, the questions were: ‘During
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this pregnancy so far have you had any of the following (followed by a
list of conditions including inﬂuenza)?’ (18 weeks gestation), ‘In the
last 3 months have you had any of the following (again followed by
the above mentioned list)?’ (32 weeks gestation) and ‘During the last
months of pregnancy (from 7 months onwards) did you experience
any of the following (followed by the above mentioned list)? (8 weeks
post-partum). Gestational inﬂuenza was coded as ‘yes’ if it was
reported at any time during pregnancy, and ‘no’, if it was not re-
ported at any point during pregnancy.
In a further analysis, we looked at exposure to inﬂuenza in
utero at the three time points separately, i.e., at 18 weeks gesta-
tion, 32 weeks gestation, and 8 weeks post-partum (7 months of
pregnancy onwards), approximately corresponding to the trime-
sters of pregnancy.
2.4. Confounding variables
We identiﬁed a priori several potential maternal/paternal and
offspring confounding variables based on previous literature in
this area (Tsuchiya et al., 2003; Brown and Derkits, 2010; Canetta
et al., 2014; Parboosing et al., 2013): parental history of psychiatric
problems (maternal or paternal history of depression, schizo-
phrenia, drug addiction, alcoholism and maternal anorexia ner-
vosa or any other maternal psychiatric problem); mother's age at
delivery; maternal education level; maternal social class; use of
antidepressants during pregnancy (recorded at 18 week and 32
week pregnancy assessments); and tobacco smoking (assessed
during the ﬁrst trimester of pregnancy). Offspring factors in-
cluded: sex; gestation age at delivery; and birth weight at delivery.
2.5. Statistical analyses
Median and interquartile ranges were used to summarise
continuous variables, and count and percentages for categorical
variables. P-values were obtained using the Kruskal-Wallis and
Chi-squared test, and chi square for trend was used for ordinal
variable (social class). Univariate and multivariable logistic re-
gression analyses were used to calculate odds ratios (OR) and 95%
conﬁdence intervals (95% CI) for hypomania as the dependent
variable and with gestational inﬂuenza as the independent vari-
able. Multivariable logistic regressions were adjusted for mother's
age at delivery, maternal education level, maternal social class,
parental history of psychiatric problems, use of antidepressants
during pregnancy, maternal smoking during pregnancy, offspring
sex, birth weight and gestation at delivery. In a secondary analysis,
multinomial logistic regression was used to calculate the OR and
95% CI for exposure to gestational inﬂuenza for hypomania with
and without previous lifetime experience PE. These regression
analyses also adjusted for the confounders listed above.
3. Results
3.1. Baseline characteristics
Compared to the original cohort, the respondents differed in
several characteristics; the respondents were signiﬁcantly more
likely to be female (64.5% versus 43.8%, Po0.001), of a white
ethnicity (96.1% versus 94.6%, P¼0.001), higher social class
(Po0.001), be of higher gestational age at birth [median IQR 40
(39–41) versus 40 (38–41), Po0001], have had a mother with a
degree (21.6% versus 9.9%, Po0.001), and mother who reported
not having inﬂuenza in pregnancy (79.8% vs 75.2%, po0.001).
Respondents were signiﬁcantly less likely to have mothers that
reported ever having depression (6.4% versus 9.9%, Po0.001) and
who smoked during pregnancy (15.2% vs 28.4%, P o0.001). They
were not signiﬁcantly more likely to report having PE not attri-
butable to sleep/fever (P¼0.091) or to have older mothers at birth
(P ¼0.178).
Table 1
Maternal, pregnancy and offspring characteristics by presence or absence of hy-
pomania in young adulthood.
Hypomania
N¼220
No hypomania
N¼2737
P value
Maternal characteristics
N, % N, %
Age at delivery
Age440 2 (1.0) 23 (0.9) 0.912
Ageo¼40 207 (99.0) 2583 (99.1)
Missing N¼142
Highest educational level
Degree or above 41 (19.8) 544 (21.4) 0.588
Other qualiﬁcation 166 (80.2) 1997 (78.6)
Missing N¼209
Social class
I 21 (11.4) 191 (8.5) 0.473
II 60 (32.4) 825 (36.6)
III 78 (42.2) 939 (41.7)
IV 14 (7.6) 131 (5.8)
V 9 (4.9) 144 (6.4)
VI 3 (1.6) 23 (1.0)
Missing N¼519
Parental history of psychia-
tric problems
Yes 25 (15.0) 328 (16.0) 0.730
No 142 (85.0) 1724 (84.0)
Missing N¼738
Smoking during pregnancy
Yes 43 (20.9) 373 (14.5) 0.014
No 163 (79.1) 2198 (85.5)
Missing N¼180
Pregnancy characteristics
Median (IQR) Median (IQR)
Gestation at delivery 40 (39–41) 40 (39–41) 0.770
Missing N¼142
N (%) N (%)
Antidepressants during
pregnancy
Yes 6 (3.05) 16 (0.65) 0.001
No 191 (96.95) 2436 (99.35)
Missing N¼308
Gestational inﬂuenza
Yes 46 (24.9) 469 (20.1) 0.121
No 139 (75.1) 1865 (79.9)
Missing N¼438
Offspring characteristics
Median (IQR) Median (IQR)
Age (years) 21.9 (21.5–22.4) 22.01 (21.5–22.4) 0.617
Missing N¼26
N (%) N (%)
Sex
Female 128 (58.2) 1786 (65.3) 0.035
Male 92 (41.8) 951 (34.8)
Missing N¼0
Median (IQR) Median (IQR)
Birth weight (g) 3380 (3100–
3720)
3460 (3120–360) 0.120
Missing N¼176
Median (IQR) Median (IQR)
HCL_32 score 19 (16–23) 15 (11–19) 0.001
Missing N¼0
N (%) N (%)
PE (age 12 or 18 years)
Yes 45 (23.1) 291 (12.2) 0.001
No 150 (76.9) 2088 (87.8)
Missing N¼383
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Overall, 220 (7.4%) respondents satisﬁed the criteria for hypo-
mania and the remaining participants were classiﬁed as a ‘no
hypomania’ comparison group (Table 1). The median HCL-32 score
was 19 (IQR 16–23) in the hypomania group and 15 (IQR 11–19) in
the ‘no hypomania’ group (po0.001). The two groups did not
differ in terms of most of the potential confounding variables
(maternal education, maternal depression, social class, maternal
age and gestational age) but the hypomanic group were more
likely to be male (41.8% versus 34.8%, po0.035), to have had a
mother who smoked during pregnancy (20.9% versus 14.5%,
po0.014) and who took antidepressants during pregnancy (3.05%
versus 0.65%, po0.001) (Table 1).
3.2. Gestational inﬂuenza and risk of hypomania
Overall, there was little evidence of an association between
exposure to inﬂuenza in utero and lifetime hypomania assessed in
young adulthood: 24.9% of mothers in the hypomania group re-
ported gestational inﬂuenza, compared to 20.1% in the comparison
group (P¼0.121) (Table 1).
3.3. Gestational inﬂuenza and risk of ‘hypomania with PE’
In a secondary analysis, we tested for an association between
gestational inﬂuenza and lifetime hypomania with (N¼45) and
without (N¼150) lifetime experience of PE, relative to controls
with no history of either hypomania or PEs (N¼2088) (Table 2).
Twenty ﬁve respondents who satisﬁed criteria for hypomania had
incomplete data for psychotic experiences and were excluded. The
three groups were similar in terms of most confounding factors
(age, gender, maternal education, maternal depression, social class,
maternal age and gestational age) but there was a difference in the
proportion of mothers who smoked during pregnancy (31.0% in
the ‘hypomania plus PE’ group, 16.6% in the ‘hypomania, no PE’
group, and 12.6% in the control group; P¼0.001). Use of anti-
depressants during pregnancy also differed signiﬁcantly between
the three groups (4.8% in the ‘hypomania plus PE’ group, 2.2% in
the ‘hypomania no PE’ group, and 0.5% in the control group;
P¼0.001).
There was evidence of a difference in prevalence of exposure to
gestational inﬂuenza between the groups (34.2% in the ‘hypoma-
nia plus PE’ group, 24.0% in the ‘hypomania no PE’ group, and
19.0% in the control group; P¼0.025) (Fig. 1 and Table 2). We
tested this association further using multinomial linear regression,
with the control group as a base group. After adjusting for con-
founding, there was little evidence that participants exposed to
gestational inﬂuenza were any more likely to be classiﬁed within
the ‘hypomania plus PE’ group than in the control group (Table 3a).
Similarly, to test the strength of association between the hy-
pomania groups, we used the ‘hypomania no PE’ as a base group in
multinomial linear regression (Table 3b). In the adjusted model
participants exposed to inﬂuenza in utero were no more likely to
be classiﬁed within the ‘hypomania plus PE’ group than in the
‘hypomania no PE’ group (Table 3b). Further sub-analyses which
divided gestational inﬂuenza exposure by trimester did not alter
these ﬁndings (Tables 4a and 4b).
4. Discussion
In this large prospective birth cohort we found little evidence of
an association between exposure to gestational inﬂuenza in utero
and risk of lifetime hypomania assessed in young adulthood, in line
with some previous work in this area (Simanek and Meier, 2015).
Although exposure to gestational inﬂuenza was more common
for the sub-group of respondents with ‘hypomania plus PE’, this
Table 2
Maternal, pregnancy and offspring characteristics: hypomania with and without PE,
versus controls.
Hypomania
plus PE N¼45
Hypomania,
no PE N¼150
Controls
(N¼2088)
P value
Maternal
characteristics
N (%) N (%) N (%)
Age at delivery
Age440 1 (2.3) 0 (0) 17 (0.9) 0.307
Ageo¼40 42 (97.7) 141 (100) 1964 (99.1)
Missing N¼118
Highest educational
level
N (%) N (%) N (%)
Degree or above 9 (20.9) 28 (20.1) 434 (22.4) 0.813
Other qualiﬁcation 34 (79.1) 111 (79.9) 1506 (77.6)
Missing N¼161
Social class
I 3 (7.3) 15 (12.2) 152 (8.75) 0.582
II 14 (34.2) 42 (34.2) 651 (37.5)
III 16 (39.0) 50 (40.7) 722 (41.5)
IV 4 (9.8) 9 (7.3) 97 (5.6)
V 3 (7.3) 6 (4.9) 105 (6.0)
VI 1 (2.4) 1 (0.8) 11 (0.6)
Missing N¼381
Parental history of
psychiatric
problems
Yes 9 (23.1) 13 (11.8) 235 (14.8) 0.235
No 30 (76.9) 97 (88.2) 1352 (85.2)
Missing N¼547
Smoking during
pregnancy
Yes 13 (31.0) 23 (16.6) 246 (12.6) 0.001
No 29 (69.1) 116 (83.5) 1713 (87.4)
Missing N¼143
Pregnancy
characteristics
Median (IQR) Median (IQR) Median
(IQR)
0.514
Gestation at delivery 40 (39–41) 40 (39–41) 40 (39–41)
Missing N¼118
Antidepressants
during pregnancy
N (%) N (%) N (%)
Yes 2 (4.8) 3 (2.2) 10 (0.5) 0.001
No 40 (95.2) 131 (97.8) 1869 (99.5)
Missing N¼228
N (%) N (%) N (%)
Gestational
inﬂuenza
Yes 14 (34.2) 30 (24.0) 342 (19.0) 0.025
No 27 (65.9) 95 (76.0) 1454 (81.0)
Missing N¼321
Offspring
characteristics
Median (IQR) Median (IQR) Median
(IQR)
Age (years)Missing
N¼16
21.9 (21.5–
22.4)
22.01 (21.5–
22.4)
21.9 (21.5–
22.4)
0.963
Median (IQR) Median (IQR) Median
(IQR)
0.181
Birth weight 3390 (3180-
3620)
3370 (3080-
3700)
3460
(3140-
3740)
Missing N¼143
Sex N (%) N (%) N (%)
Female 29 (64.4) 84 (56.0) 1328 (63.6)
Male 16 (35.6) 66 (44.0) 760 (36.4) 0.173
Missing¼0
Median (IQR) Median (IQR) Median
(IQR)
0.001
HCL_32 score 20 (18–23) 19 (16–22) 15 (11–19)
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association attenuated after adjusting for confounding factors,
with conﬁdence intervals including the null value. Previous work
has identiﬁed an association between serologically-documented
gestational inﬂuenza exposure and a sub-group of bipolar disorder
with psychotic features (Canetta et al., 2014), although the range of
possible confounding factors assessed in that study (including
maternal smoking during pregnancy) was limited. It is however
difﬁcult to be certain that adjusting for additional confounders
within the study by Canetta et al., (2014) would have substantially
changed their main ﬁnding.
4.1. Strengths and limitations
The ALSPAC birth cohort is a large, well-characterised and re-
presentative sample of young adults from the UK and our study has
the advantage of a prospective design, with relatively large numbers
of affected individuals with bipolar disorder, in contrast to some
studies (Canetta et al., 2014; Parboosing et al., 2013). Our study also
Fig. 1. Association between Exposure to Gestational Inﬂuenza and Hypomania with
and without PE.
Table 3a
Gestational inﬂuenza exposure: hypomania with and without PE, relative to con-
trols as a base group (multinomial logit regression)a.
Total N¼1459 Gestational
inﬂuenza
Univariable Multivariable
N (%) OR
(95% CI)
P value OR
(95% CI)
P value
Hypomania no
PE
Yes¼22 (24.2) 1.36
(0.83,
2.24)
0.227 1.36 (0.82,
2.25)
0.231
No¼69 (75.8)
Hypomania and
PE
Yes¼10 (27.8) 1.64
(0.78,
3.45)
0.191 1.50 (0.70,
3.22)
0.299
No¼26 (72.2)
a Multivariable model is adjusted for high maternal age, maternal education
(degree), maternal social class, use of antidepressants during pregnancy, parental
psychiatric history, maternal smoking during pregnancy, offspring sex, birth weight
and gestation at birth.
Table 3b
Gestational inﬂuenza exposure: hypomania with PE and controls, relative to hy-
pomania without PE as a base group (multinomial logit regression)a.
Total N¼1459 Gestational
inﬂuenza
Univariate Multivariable
N (%) OR
(95% CI)
P value OR
(95% CI)
P value
Controls (no hypo-
mania no PE)
Yes¼253 (19.0) 0.74
(0.45,
1.21)
0.227 0.74
(0.44,
1.22)
0.231
No¼1079
(81.0)
Hypomania and PE Yes¼10 (27.8) 1.21
(0.50,
2.89)
0.674 1.10
(0.45,
2.69)
0.831
No¼26 (72.2)
a Multivariable model is adjusted for high maternal age, maternal education
(degree), maternal social class, use of antidepressants during pregnancy, parental
psychiatric history, maternal smoking during pregnancy, offspring sex, birth weight
and gestation at birth.
Table 4a
Gestational inﬂuenza exposure by trimester of exposure: hypomania with and
without PE, relative to controls as a base group (multinomial logit regression)a.
Gestational
inﬂuenza
Univariate Multivariable
Trimester 1
N¼1303
N (%) OR
(95% CI)
P value OR
(95% CI)
P value
Hypomania no
PE
Yes¼12 (14.8) 1.66
(0.87,
3.16)
0.122 1.66 (0.86,
3.17)
0.128
No¼69 (85.2)
Hypomania and
PE
Yes¼4 (13.3) 1.47
(0.50,
4.28)
0.481 1.32 (0.44,
3.99)
0.626
No¼26 (86.7)
Trimester 2
N¼1236
N (%) OR
(95% CI)
P value OR
(95% CI)
P value
Hypomania no
PE
Yes¼4 (5.5) 1.14
(0.40,
3.23)
0.809 1.15 (0.40,
3.25)
0.794
No¼69 (94.5)
Hypomania and
PE
Yes¼3 (10.3) 2.26
(0.67,
7.71)
0.191 2.57 (0.73,
9.12)
0.144
No¼26 (89.7)
Trimester 3
N¼1229
N (%) OR
(95% CI)
P value OR
(95% CI)
P value
Hypomania no
PE
Yes¼6 (8.0) 1.96
(0.81,
4.73)
0.137 1.88 (0.77,
4.60)
0.167
No¼69 (92.0)
Hypomania and
PE
Yes¼1 (3.7) 0.87
(0.12,
6.51)
0.888 0.53 (0.07,
4.24)
0.548
No¼26 (96.3)
a Multivariable model is adjusted for high maternal age, maternal education
(degree), maternal social class, use of antidepressants during pregnancy, parental
psychiatric history, maternal smoking during pregnancy, offspring sex, birth weight
and gestation at birth.
Table 4b
Gestational inﬂuenza exposure by trimester of exposure: hypomania with PE and
controls, relative to hypomania without PE as a base group (multinomial logit
regression)a.
Gestational
inﬂuenza
Univariate Multivariable
Trimester 1
N¼1303
N (%) OR
(95% CI)
P value OR
(95% CI)
P value
Controls (no hypo-
mania no PE)
Yes¼113 (9.5) 0.60
(0.32,
1.15)
0.122 0.60
(0.32,
1.16)
0.128
No¼1079
(90.5)
Hypomania and PE Yes¼4 (13.3) 0.89
(0.26,
3.00)
0.844 0.80
(0.23,
2.78)
0.720
No¼26 (86.7)
Trimester 2
N¼1236
N (%) OR
(95% CI)
P value OR
(95% CI)
P value
Controls (no hypo-
mania no PE)
Yes¼55 (4.9) 0.88
(0.31,
2.50)
0.809 0.87
(0.30,
2.49)
0.794
No¼1079
(95.2)
Hypomania and PE Yes¼3 (10.3) 2.00
(0.42,
9.50)
0.388 2.24
(0.45,
11.10)
0.325
No ¼26
(89.7)
Trimester 3
N¼1229
N (%) OR
(95% CI)
P value OR
(95% CI)
P value
Controls (no hypo-
mania no PE)
Yes¼48 (4.3) 0.51
(0.21,
1.24)
0.137 0.53
(0.22,
1.30)
0.167
No¼1079
(95.7)
Hypomania and PE Yes¼1 (3.7) 0.44
(0.05,
3.85)
0.460 0.28
(0.03,
2.59)
0.262
No¼26 (96.3)
a Multivariable model is adjusted for high maternal age, maternal education
(degree), maternal social class, use of antidepressants during pregnancy, parental
psychiatric history, maternal smoking during pregnancy, offspring sex, birth weight
and gestation at birth.
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ﬁlls an important gap in the literature between clinical and popu-
lation samples by assessing features of hypomania within a non-
clinical cohort of young adults. This work could be considered to
represent an advance on previous reports because the level of detail
available on the ALSPAC cohort allows for a much wider range of
potential confounding factors to be taken into account within ana-
lyses, including mother's age at delivery, maternal education level,
maternal social class, parental history of psychiatric problems, use of
antidepressants during pregnancy, maternal smoking during preg-
nancy, offspring sex, birth weight and gestation at delivery.
However, we acknowledge a number of limitations. The re-
sponse rate for those who were sent the HCL-32 questionnaire was
36.8%, which may have resulted in some analyses being under-
powered to detect a true effect. There was a selection bias amongst
the respondents obvious from the statistically signiﬁcant differ-
ences in some socio-demographic factors and gestational age at
delivery. This may have resulted in over-representation of ‘pro-
tective’ factors, such as higher education or higher social class
within our ﬁnal sample and may have weakened the association
between ‘hypomania’ and exposure to gestational inﬂuenza. The
under-representation of mothers who reported inﬂuenza in the
ﬁnal sample could also have underestimated the effect. Participant
attrition has been an issue in studies using more recent outcome
measures within ALSPAC and is a potential source of bias in this
study. It is however possible that the effect sizes we have observed
might be an underestimate because offsprings exposed to inﬂu-
enza in utero (as well as those with bipolar features) were more
likely to be missing. Our outcome measure, the HCL-32, may be
subject to reporting bias because it relies on self-report in areas
such as risk-taking, sexual activity and alcohol use. However, this
instrument is well validated as a screening tool for bipolar dis-
order (Meyer et al., 2014; Vieta et al., 2007). It is also possible that
respondents completed the HCL-32 with reference to a period of
intoxication with recreational drugs, even though the opening
statement speciﬁcally asks that they consider “a period when
[they] were in a high state, not related to recreational drug use”.
There have not yet been sensitivity and speciﬁcity tests of the HCL-
32 as a categorical measure which includes both duration and
impact on functioning as criteria but it is likely that by including
these features we have improved the sensitivity for a diagnosis of
hypomania because previous methods have tended to focus just
on a threshold score on the HCL-32, usually 14 out of 32 (Carvalho
et al., 2014; Meyer et al., 2007; Vieta et al., 2007). It is also possible
that as our study is set in respondents’ young adulthood, larger
effect sizes could have been observed if the follow-up was longer.
Another potential limitation relates to the self-reported nature
of gestational inﬂuenza by mothers. It is possible that some mo-
thers may have been exposed to inﬂuenza but did not report this
when asked, for example, because of mild symptoms. Clearly ser-
ological data on inﬂuenza infection during pregnancy would have
been preferable but was not available for this study.
5. Conclusions
Overall, within a birth cohort followed up into young adult-
hood, we did not ﬁnd evidence that a maternal report of inﬂuenza
infection during pregnancy was a risk factor for lifetime hypo-
mania (or lifetime hypomania plus PE) assessed in young adult-
hood. Further work in this area should test whether observed
associations are likely to be causal or due to confounding in a more
rigorous manner than has been done to date. There may also be
value in assessing dimensional aspects of psychopathology across
the mood disorder-psychosis spectrum, rather than with outcomes
deﬁned solely by formal diagnostic categories (such as within ICD-
10 and DSM5) (Cuthbert and Insel, 2013; Insel et al., 2010).
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